Citadel Advisors’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-17,627
| Closed | -$10K | – | 4557 |
|
|
2016
Q3 | $10K | Buy |
+17,627
| New | +$10K | ﹤0.01% | 3504 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4421 |
|
|
2016
Q1 | – | Sell |
-38,499
| Closed | -$123K | – | 4608 |
|
|
2015
Q4 | $123K | Buy |
38,499
+20,661
| +116% | +$66K | ﹤0.01% | 3177 |
|
|
2015
Q3 | $111K | Buy |
+17,838
| New | +$111K | ﹤0.01% | 3358 |
|
|
2015
Q2 | – | Sell |
-11,805
| Closed | -$87K | – | 4485 |
|
|
2015
Q1 | $87K | Buy |
11,805
+3,501
| +42% | +$25.8K | ﹤0.01% | 3279 |
|
|
2014
Q4 | $44K | Buy |
8,304
+1,569
| +23% | +$8.31K | ﹤0.01% | 3428 |
|
|
2014
Q3 | $34K | Sell |
6,735
-21,924
| -76% | -$111K | ﹤0.01% | 3222 |
|
|
2014
Q2 | $192K | Buy |
28,659
+16,669
| +139% | +$112K | ﹤0.01% | 2824 |
|
|
2014
Q1 | $87K | Buy |
+11,990
| New | +$87K | ﹤0.01% | 3114 |
|